Showing results (221-230 of 352) with videos related to
Sort By:
Pageof 36
Health Economics|May 6, 2004
When does quality-adjusting life-years matter in cost-effectiveness analysis?Richard H Chapman, Marc Berger, Milton C Weinstein, et al.Medical Care|August 29, 2022
Effect of the 2012 US Preventive Services Task Force Recommendations on Prostate-Specific Antigen Screening in a Medicare Advantage PopulationYingying Zhu, Benjamin Koethe, Daniel A Ollendorf, et al.Pharmacoeconomics|September 24, 2021
Principles of Economic Evaluation in a Pandemic Setting: An Expert Panel Discussion on Value Assessment During the Coronavirus Disease 2019 PandemicYumi Asukai, Andrew Briggs, Louis P Garrison, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 29, 2025
Changes in Out-of-Pocket Drug Expenditures Among Medicare Beneficiaries With Dementia Under the Inflation Reduction Act: A Simulation StudyYingying Zhu, Natalia Olchanski, Karen M Freund, et al.Critical Care Medicine|April 16, 2019
Cost-Effectiveness Studies in the ICU: A Systematic ReviewM Elizabeth Wilcox, Kelsey Vaughan, Christopher A K Y Chong, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 22, 2022
The Impact of Broader Value Elements on Cost-Effectiveness Analysis: Two Case StudiesSiyu Ma, Natalia Olchanski, Joshua T Cohen, et al.JAMA|July 23, 2002
Long-term persistence in use of statin therapy in elderly patientsJoshua S Benner, Robert J Glynn, Helen Mogun, et al.Health Affairs (Project Hope)|February 4, 2015
Medicare is scrutinizing evidence more tightly for national coverage determinationsJames D Chambers, Matthew Chenoweth, Michael J Cangelosi, et al.The Oncologist|September 28, 2024
Healthcare resource utilization and associated cost in patients with metastatic non-small cell lung cancer treated in the immunotherapy eraLior Apter, Sarah Sharman Moser, Sivan Gazit, et al.Health Research Policy and Systems|December 4, 2016
The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and BangladeshYot Teerawattananon, Sripen Tantivess, Inthira Yamabhai, et al.Pageof 36